Nephros
NEPH
19 hedge funds and large institutions have $32M invested in Nephros in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 2 closing their positions.
1.95% more ownership
Funds ownership: 47.55% → 49.5% (+2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 21 → 19 (-2)
10% less capital invested
Capital invested by funds: $35.7M → $32M (-$3.7M)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Cowen Prime Advisors
New York
|
+$1.95M |
| 2 |
Millennium Management
New York
|
+$183K |
| 3 |
EP
Elkhorn Partners
Omaha,
Nebraska
|
+$20.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.1K |
| 5 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
+$9.09K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$334K |
| 2 |
OMC
Overbrook Management Corp
New York
|
-$287K |
| 3 |
Renaissance Technologies
New York
|
-$150K |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$72.8K |
| 5 |
BlackRock
New York
|
-$52.3K |
NEPH Hedge Fund Activity: Q3 2020 in Review
19 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q3 2020, worth a combined $32M — down 10% from $35.7M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NEPH and 0 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 6 added.
The largest buyer was Cowen Prime Advisors, adding an estimated $1.95M. The largest seller was Essex Investment Management, exiting entirely with an estimated $334K sold.
- 19 institutional investors held Nephros (NEPH) as of Q3 2020, down from 21 in Q2 2020.
- Funds reported $32M of Nephros stock for Q3 2020, down 10% quarter-over-quarter.
- 0 funds opened new Nephros positions in Q3 2020 and 2 closed out, a net change of -2 holders.
- The largest Nephros buyer in Q3 2020 was Cowen Prime Advisors, an estimated $1.95M added.
- The largest Nephros seller in Q3 2020 was Essex Investment Management, an estimated $334K sold.
Based on aggregated 13F filings for Q3 2020.